Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

R&D Overcrowding: A Challenge For Biopharma But Great For Patients And Payers
Forbes
Thursday, January 9, 2014 - 9:11am
tags:
R&D
Drugmaker Teva picks turnaround specialist as CEO
Reuters
Thursday, January 9, 2014 - 8:43am
tags:
Teva, Pharma CEOs, Erez Vigodman
GSK melanoma drug combination wins accelerated U.S. approval
Yahoo/Reuters
Thursday, January 9, 2014 - 8:37am
tags:
GSK, FDA, Tafinlar, Mekinist, melanoma
France OKs sales of medicine derived from cannabis
Yahoo/AP
Thursday, January 9, 2014 - 8:34am
tags:
France, cannabis, Sativex, MS, multiple sclerosis, GW Pharma
Amgen Vs. Merck, Lilly In Osteoporosis Competition
Seeking Alpha
Thursday, January 9, 2014 - 8:33am
tags:
Amgen, Merck, Eli Lilly, osteoporosis, romosozumab, UCB Pharmaceuticals, Prolia, Forteo, Fosamax
J&J petitions FDA to require "similar" names for biosimilars, biologics
Yahoo/Reuters
Thursday, January 9, 2014 - 8:30am
tags:
JNJ, FDA, biosimilars, Mylan, Novartis
Novartis Accused of Paying Kickbacks for Exjade Sales
Bloomberg
Thursday, January 9, 2014 - 8:28am
tags:
Novartis, Exjade, kickbacks, BioScrip
New ED Drug: Analysis Of Vivus's Prospects
Seeking Alpha
Thursday, January 9, 2014 - 8:26am
tags:
erectile dysfunction, Vivus, Stendra, Pfizer, Viagra, Cialis, Eli Lilly, Actavis, Auxillium, Bayer
Transgene to Move Lung Cancer Drug Into Advanced Tests
Bloomberg
Thursday, January 9, 2014 - 8:23am
tags:
Transgene, TG-4010, non-small cell lung cancer
Novartis Said to Be in Talks With Merck on $5 Bln Swap of Business Units
Bloomberg
Thursday, January 9, 2014 - 8:22am
tags:
Novartis, Merck, vaccines, animal health, OTC
Bristol-AstraZeneca Diabetes Drug Wins U.S. FDA Approval
Bloomberg
Wednesday, January 8, 2014 - 4:20pm
tags:
Dapagliflozin, FDA, Bristol-Myers Squibb, diabetes, AstraZeneca
Novadaq's Story Continues To Come Along
Seeking Alpha
Wednesday, January 8, 2014 - 4:17pm
tags:
Novadaq Technologies, devices, Covidien, JNJ, Intuitive Surgical
Roche, Teva and AstraZeneca are all said to be in the mix to buy Celltrion
Fierce Pharma
Wednesday, January 8, 2014 - 11:11am
tags:
Roche, Teva, AstraZeneca, biosimilars, M&A, Celltrion, South Korea
This Overvalued Biotech is in Danger of Plummeting as Much as 30%
Yahoo/Street Authority
Wednesday, January 8, 2014 - 10:18am
tags:
Celgene
Catalyst Pharma says autoimmune disorder drug safe for heart
Reuters
Wednesday, January 8, 2014 - 10:01am
tags:
Catalyst Pharmaceutical Partners, Lambert-Eaton myasthenic syndrome, Firdapse
Is FDA Seeking NSA Capabilities?
Pharma Marketing Blog
Wednesday, January 8, 2014 - 10:00am
tags:
FDA, social media
EarlySense Receives FDA Clearance for New Bedside Monitor
Yahoo
Wednesday, January 8, 2014 - 9:53am
tags:
devices, FDA, Patient Monitoring System, EarlySense
Former CBO director calls for an end to the medtech tax
Mass Device
Wednesday, January 8, 2014 - 9:48am
tags:
device tax, Congressional Budget Office
Medtronic spends $160M on Tyrx and its antibacterial envelopes
Fierce Medical Devices
Wednesday, January 8, 2014 - 9:43am
tags:
Medtronic, devices, Tyrx, antibacterial envelopes, M&A
J&J Innovation launches a discovery pact with fledgling upstart Scholar Rock
Fierce Biotech
Wednesday, January 8, 2014 - 9:39am
tags:
Scholar Rock, JNJ Innovation, JNJ, autoimmune disease

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.